Skip to content

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06381232
Enrollment
20000
Registered
2024-04-24
Start date
2018-07-23
Completion date
2028-07-23
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Health, Wellness

Brief summary

The purpose of the study is to collect and analyze physiological, physical, and molecular data from a diverse population to increase our understanding of how such parameters are associated with health and disease.

Detailed description

The analyses conducted by Viome will include, but are not limited to: genetic, transcriptomic, metabolomic, physiological, and physical. The samples collected from participants may include any of these: stool, blood, saliva, cheek swab, vaginal, breast milk/colostrum, nasal swabs or washes, and urine. Study participants will collect the clinical samples and ship them to Viome labs or CROs (Contract Research Organizations), where they will be analyzed. The objective of the study is to establish which foods correspond with increased wellness, and which foods correspond to decreased wellness. The study hypothesis is that by monitoring the patterns of food intake and lifestyle parameters, in conjunction with non-invasive sample testing, personalized diet and lifestyle recommendations can be elucidated.

Interventions

OTHERNo Intervention

This is an observational study, there are no interventions.

Sponsors

Viome
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Anyone that resides in the US at the time of enrollment.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Molecular Determinants of Health and Disease10 yearsWe measure thousands of transcript levels in multiple clinical samples. The primary outcome measures are changes in quantitative gene expression, microbial or human, as a result of transitioning from a healthy state to a disease.

Countries

United States

Contacts

Primary ContactMomchilo Vuyisich, PhD
studies@viome.com(425) 300-6933

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026